Yu Z, Li L, Cheng P, Zhang H, Xu S
Sci Rep. 2024; 14(1):29486.
PMID: 39604506
PMC: 11603295.
DOI: 10.1038/s41598-024-80974-2.
Ozgur Gundeslioglu O, Haytoglu Z, Gumus H, Ekinci F, Kibar F, Cay U
Eur J Clin Microbiol Infect Dis. 2024; 43(12):2361-2369.
PMID: 39352616
DOI: 10.1007/s10096-024-04948-y.
Iqbal F, Barche A, Shenoy P, Lewis L, Purkayastha J, Vandana K
J Epidemiol Glob Health. 2024; 14(4):1525-1535.
PMID: 39347930
PMC: 11652472.
DOI: 10.1007/s44197-024-00303-8.
Sundaresan A, Gangwar J, Murugavel A, Mohan G, Ramakrishnan J
AMB Express. 2024; 14(1):78.
PMID: 38965152
PMC: 11224175.
DOI: 10.1186/s13568-024-01737-w.
Chen Y, Fang C, Luo J, Pan X, Gao Z, Tang S
Infect Drug Resist. 2024; 17:1987-1997.
PMID: 38800585
PMC: 11122319.
DOI: 10.2147/IDR.S463105.
Off-Label Use of Ceftazidime/Avibactam for the Treatment of Pan-Drug-Resistant in a Neonate: Case Report and Literature Review.
Mangarov I, Georgieva R, Petkova V, Nikolova I
Antibiotics (Basel). 2023; 12(8).
PMID: 37627722
PMC: 10451246.
DOI: 10.3390/antibiotics12081302.
Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant -Producing Carrying .
Zarras C, Iosifidis E, Simitsopoulou M, Pappa S, Kontou A, Roilides E
Antibiotics (Basel). 2023; 12(8).
PMID: 37627710
PMC: 10451261.
DOI: 10.3390/antibiotics12081290.
Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review.
Venuti F, Romani L, De Luca M, Tripiciano C, Palma P, Chiriaco M
Microorganisms. 2023; 11(7).
PMID: 37512970
PMC: 10385558.
DOI: 10.3390/microorganisms11071798.
Ceftazidime-Avibactam Treatment for Bacteremia in Preterm Infants in NICU: A Clinical Experience.
Marino A, Pulvirenti S, Campanella E, Stracquadanio S, Ceccarelli M, Micali C
Antibiotics (Basel). 2023; 12(7).
PMID: 37508265
PMC: 10376358.
DOI: 10.3390/antibiotics12071169.
Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates.
Kontou A, Kourti M, Iosifidis E, Sarafidis K, Roilides E
Antibiotics (Basel). 2023; 12(6).
PMID: 37370391
PMC: 10294916.
DOI: 10.3390/antibiotics12061072.
New Antimicrobials for the Treatment of Neonatal Sepsis Caused by Multi-Drug-Resistant Bacteria: A Systematic Review.
Poggi C, Dani C
Antibiotics (Basel). 2023; 12(6).
PMID: 37370275
PMC: 10295431.
DOI: 10.3390/antibiotics12060956.
Use of Antibiotics in Preterm Newborns.
Simeoli R, Cairoli S, Decembrino N, Campi F, Vici C, Corona A
Antibiotics (Basel). 2022; 11(9).
PMID: 36139921
PMC: 9495226.
DOI: 10.3390/antibiotics11091142.
Antimicrobial Resistance and Associated Risk Factors of Gram-Negative Bacterial Bloodstream Infections in Tikur Anbessa Specialized Hospital, Addis Ababa.
Beshah D, Desta A, Belay G, Abebe T, Gebreselasie S, Tessema T
Infect Drug Resist. 2022; 15:5043-5059.
PMID: 36068835
PMC: 9441145.
DOI: 10.2147/IDR.S371654.
Therapeutic Options and Outcomes for the Treatment of Neonates and Preterms with Gram-Negative Multidrug-Resistant Bacteria: A Systematic Review.
Chiusaroli L, Liberati C, Caseti M, Rulli L, Barbieri E, Giaquinto C
Antibiotics (Basel). 2022; 11(8).
PMID: 36009956
PMC: 9404799.
DOI: 10.3390/antibiotics11081088.
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients.
Giamarellou H, Karaiskos I
Antibiotics (Basel). 2022; 11(8).
PMID: 35892399
PMC: 9394369.
DOI: 10.3390/antibiotics11081009.
Intravenous Ceftazidime-Avibactam in Extremely Premature Neonates With Carbapenem-Resistant Enterobacteriaceae: Two Case Reports.
Asfour S, Alaklobi F, Abdelrahim A, Taha M, Asfour R, Khalil T
J Pediatr Pharmacol Ther. 2022; 27(2):192-197.
PMID: 35241992
PMC: 8837207.
DOI: 10.5863/1551-6776-27.2.192.
Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Clinical Isolates.
Han R, Yang X, Yang Y, Guo Y, Yin D, Ding L
Microbiol Spectr. 2022; 10(1):e0109221.
PMID: 35019685
PMC: 8865541.
DOI: 10.1128/spectrum.01092-21.
Neonatal multidrug-resistant gram-negative infection: epidemiology, mechanisms of resistance, and management.
Flannery D, Chiotos K, Gerber J, Puopolo K
Pediatr Res. 2021; 91(2):380-391.
PMID: 34599280
PMC: 8819496.
DOI: 10.1038/s41390-021-01745-7.
